Potential application of oligodeoxynucleotides for rheumatoid arthritis
Tomita, T.; Hashimoto, H.; Kunugiza, Y.; Yoshikawa, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 1): 660-665
2005
ISSN/ISBN: 0047-1852 PMID: 15799438 Document Number: 591991
Document emailed within 1 workday
Related Documents
Souness, J.E.; Foster, M. 1998: Potential of phosphodiesterase type of IV inhibitors in the treatment of rheumatoid arthritis Idrugs: the Investigational Drugs Journal 1(5): 541-553Dudich, E. 2007: MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases Current Opinion in Molecular Therapeutics 9(6): 603-610
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Kamper, E.F.; Kopeikina, L.T.; Trontzas, P.; Potamianou, A.; Tsiroglou, E.; Stavridis, J.C. 2000: The effect of disease activity related cytokines on the fibrinolytic potential and cICAM-1 expression in rheumatoid arthritis Journal of Rheumatology 27(11): 2545-2550
Ben Kilani, M.S.; Cornélis, F.ço.; Olaso, R.; Chaudru, V.; Petit-Teixeira, E. 2019: Investigation of candidate gene copy number identifies FCGR3B as a potential biomarker for rheumatoid arthritis Clinical and Experimental Rheumatology 37(6): 923-928
Cuchacovich, M.; Gatica, H.; Grigg, D.M.; Pizzo, S.V.; Gonzalez-Gronow, M. 1996: Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis Journal of Rheumatology 23(1): 44-51
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Scherler, M. 1978: Poncet--rheumatoid arthritis. Four cases of rheumatoid arthritis treated with tuberculostatics (author's transl1 Therapeutische Umschau. Revue Therapeutique 35(3): 201-206
Tari, A.M. 2000: Preparation and application of liposome-incorporated oligodeoxynucleotides Methods in Enzymology 313: 372-388
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Singh, N.; Garg, S.C. 1988: Rheumatoid arthritis presenting as arthritis mutilans with rheumatoid lung Journal of the Indian Medical Association 86(1): 14-15
Yu, C.; Li, M.; Duan, X.; Fang, Y.; Li, Q.; Wu, R.; Liu, S.; Wang, Y.; Wu, Z.; Shi, X.; Jiang, Z.; Wang, Y.; Hsieh, E.D.; Jin, S.; Jiang, N.; Wang, Q.; Zhao, Y.; Tian, X.; Zeng, X. 2018: Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis Clinical and Experimental Rheumatology 36(5): 836-840
Lineker, S.C.; Badley, E.M.; Hughes, E.A.; Bell, M.J. 1997: Development of an instrument to measure knowledge in individuals with rheumatoid arthritis: the ACREU rheumatoid arthritis knowledge questionnaire Journal of Rheumatology 24(4): 647-653
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Førre, O.; Dobloug, J.H.; Natvig, J.B. 1982: Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction Scandinavian Journal of Immunology 15(2): 227-231
Coaccioli, S.; Pinoca, F.; Giuliani, M.; Landucci, P.; Sabatini, C.; Puxeddu, A. 2007: Definition of adult-onset rheumatoid arthritis from elderly-onset rheumatoid arthritis by studying T-lymphocyte subpopulations, their soluble receptors and soluble receptor of interleukin-2 La Clinica Terapeutica 158(4): 303-306